HD
Habib J Dable
CEO and PresidentDirector

Habib J Dable insider trades: Acceleron Pharma (XLRN) stock sales

CEO and President, Acceleron Pharma Last trade Jul 2, 2021 42 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2018
9
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Habib reports to the SEC

and 3 more companies

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 2, 2021XLRN↓ Sell$12.7M
Jan 5, 2021XLRN↓ Sell$516K
Jul 1, 2020XLRN↓ Sell$4.8M
Jan 3, 2020XLRN↓ Sell$191K
Sep 10, 2019XLRN↓ Sell$254K
Apr 9, 2019XLRN↓ Sell$333K
Jan 3, 2019XLRN↓ Sell$85K
Dec 4, 2018XLRN↓ Sell$672K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Habib J Dable's insider trades

Habib J Dable is CEO and President at Acceleron Pharma (XLRN). Since Dec 4, 2018, Habib has reported no open-market purchases and 8 sales worth $19.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (30 filings), shares returned to the company (5 filings), other transactions (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XLRN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.